Atlas Trials

Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

Clinical trial NCT01743859 · COMPLETED

Trial details

NCT number
NCT01743859
Sponsor
University of Colorado, Denver
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2012-12-06
Primary completion
2016-04-27
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.